Sangrigoli V, Carrà G, Lazzara N, Micale F, Puleo M G, Bonaccorsi R
Clin Ter. 1989 May 15;129(3):207-9.
Fifty-eight patients with acute and chronic pathology of the lower limbs were treated with daily oral doses of 96 mg of mesoglycan, a drug having antithrombotic and fibrinolytic properties. After a 3-months trial both clinical picture and instrumental parameters were found to be improved.
58例患有下肢急慢性病变的患者每日口服96毫克的葡糖胺聚糖进行治疗，该药物具有抗血栓形成和纤维蛋白溶解特性。经过3个月的试验，发现临床症状和仪器检查参数均有所改善。
